VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 186 filers reported holding VIKING THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $409,037 | -36.3% | 39,597 | 0.0% | 0.10% | -32.4% |
| Q2 2023 | $641,867 | +13.4% | 39,597 | +16.5% | 0.15% | +10.4% |
| Q1 2023 | $565,934 | +85.1% | 33,990 | +4.5% | 0.13% | +81.1% |
| Q4 2022 | $305,726 | +133.4% | 32,524 | 0.0% | 0.07% | +94.7% |
| Q3 2022 | $131,000 | +22.4% | 32,524 | 0.0% | 0.04% | +46.2% |
| Q2 2022 | $107,000 | +55.1% | 32,524 | +41.0% | 0.03% | +85.7% |
| Q1 2022 | $69,000 | -19.8% | 23,074 | +23.5% | 0.01% | -17.6% |
| Q4 2021 | $86,000 | -26.5% | 18,679 | 0.0% | 0.02% | -37.0% |
| Q3 2021 | $117,000 | +4.5% | 18,679 | 0.0% | 0.03% | +8.0% |
| Q2 2021 | $112,000 | +10.9% | 18,679 | +4.5% | 0.02% | -3.8% |
| Q1 2021 | $101,000 | +18.8% | 17,879 | +21.8% | 0.03% | +13.0% |
| Q4 2020 | $85,000 | +2.4% | 14,679 | -1.3% | 0.02% | +4.5% |
| Q3 2020 | $83,000 | – | 14,879 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |